Alerts will be sent to your verified email
Verify Email
CHEMOPH
|
Chemo Pharma Labs
|
Hamps Bio
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.51 % | 17.75 % | 13.7 % |
|
5yr average Equity Multiplier
|
1.01 | 2.66 | 1.24 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.39 | 0.36 |
|
5yr Avg Net Profit Margin
|
0.0 | 5.48 % | 71.53 % |
|
Price to Book
|
1.39 | 0.0 | 2.21 |
|
P/E
|
49.0 | 39.15 | 54.61 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 10.22 Days | 68.18 Days |
|
Inventory Days
|
0.0 | 38.15 Days | 62.21 Days |
|
Days Receivable
|
0.0 | 49.29 Days | 10.88 Days |
|
Days Payable
|
0.0 | 79.37 Days | 199.95 Days |
|
5yr Average Interest Coverage Ratio
|
794.39 | 3.3 | 815.2 |
|
5yr Avg ROCE
|
-3.17 % | 22.28 % | 19.97 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 15.08 % | -101.39 % |
|
5 yr average Debt to Equity
|
0.01 | 1.2 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | 33.03 % | 0.0 |
|
5yr Average Return on Assets
|
-4.13 % | 7.45 % | 10.86 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.89 % | 71.99 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 1.02 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chemo Pharma Labs
|
Hamps Bio
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|